Form 4: Privia Health Group EVP David Mountcastle Sells 100,000 Shares
SEC Form 4 Filing
David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., sold 100,000 shares of common stock at an average price of $25.15 on February 14, 2025, according to a Form 4 filing.
Summary
- On February 14, 2025, David Mountcastle, the EVP & Chief Financial Officer of Privia Health Group, Inc., sold 100,000 shares of common stock.
- The sale was executed at a weighted average price of $25.15 per share, with individual transactions ranging from $25.00 to $25.40.
- Following the transaction, Mountcastle directly owns 157,727 shares and indirectly owns 8,695 shares through his spouse.
- The sale was conducted under a pre-arranged 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on insider information.
Stakeholder Impact
- The stock sale by a high-ranking executive could potentially create uncertainty among shareholders, although the use of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date of stock sale transaction |
| 02/19/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.